99% Savings - Buy Just @1 Rs X
Triolsertain is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Triolsertain safe for pregnant women?
Triolsertain is safe for pregnant women.
Is the use of Triolsertain safe during breastfeeding?
Breastfeeding women can safely use Triolsertain.
What is the effect of Triolsertain on the Kidneys?
Very few cases of side effects of Triolsertain on kidney have been reported.
What is the effect of Triolsertain on the Liver?
Triolsertain is rarely harmful for the liver.
What is the effect of Triolsertain on the Heart?
Very few cases of side effects of Triolsertain on the heart have been reported.
Triolsertain should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Triolsertain unless your doctor advises you to do so -
Is this Triolsertain habit forming or addictive?
Triolsertain is not addictive in nature.
Interaction between Food and Triolsertain
Triolsertain may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Triolsertain
Consult your doctor before consuming alcohol while taking Triolsertain as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448